Bluejay Diagnostics Inc [NASDAQ: BJDX] stock went on a downward path that fall over -5.87% on Monday, amounting to a one-week price decrease of less than -15.24%.
Over the last 12 months, BJDX stock dropped by -99.64%. The one-year Bluejay Diagnostics Inc stock forecast points to a potential upside of 99.96. The average equity rating for BJDX stock is currently 3.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $1.80 million, with 16.55 million shares outstanding and 16.47 million shares in the current float. Compared to the average trading volume of 2.19M shares, BJDX stock reached a trading volume of 7795988 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Bluejay Diagnostics Inc [BJDX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BJDX shares is $256.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BJDX stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Bluejay Diagnostics Inc is set at 0.02 The Price to Book ratio for the last quarter was 0.03, with the Price to Cash per share for the same quarter was set at 0.49.
BJDX Stock Performance Analysis:
Bluejay Diagnostics Inc [BJDX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -15.24. With this latest performance, BJDX shares dropped by -27.96% in over the last four-week period, additionally sinking by -97.69% over the last 6 months – not to mention a drop of -99.64% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BJDX stock in for the last two-week period is set at 24.52, with the RSI for the last a single of trading hit 22.85, and the three-weeks RSI is set at 27.53 for Bluejay Diagnostics Inc [BJDX]. The present Moving Average for the last 50 days of trading for this stock 0.2004, while it was recorded at 0.1161 for the last single week of trading, and 3.6407 for the last 200 days.
Insight into Bluejay Diagnostics Inc Fundamentals:
Bluejay Diagnostics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.38 and a Current Ratio set at 4.38.
Bluejay Diagnostics Inc [BJDX] Institutonal Ownership Details
There are presently around $1.02%, or 1.04%% of BJDX stock, in the hands of institutional investors.
